Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis.

Clinical trial NCT06176560 · UNKNOWN

Trial details

NCT number: NCT06176560
Sponsor: Faes Farma, S.A.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Colitis, Ulcerative

Start date: 2024-03-01
Primary completion: 2025-08-01
Enrollment: 376

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.